MREO NASDAQ
Mereo BioPharma Group plc
1W: +2.6%
1M: +42.1%
3M: +20.0%
YTD: -25.6%
1Y: -81.5%
3Y: -71.9%
5Y: -84.2%
$0.38
+0.01 (+3.52%)
Weekly Expected Move ±14.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
ESG Scores — MREO
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (15)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 55.8 | 72.7 | 76.8 | 68.5 | SEC ↗ |
| 2026-03-31 | 10-Q | 55.8 | 73.2 | 76.8 | 68.6 | SEC ↗ |
| 2025-12-31 | 10-K | 58.4 | 63.7 | 61.5 | 61.2 | SEC ↗ |
| 2025-03-31 | 10-Q | 55.8 | 73.5 | 76.3 | 68.5 | SEC ↗ |
| 2024-12-31 | 10-K | 59.0 | 64.4 | 62.2 | 61.9 | SEC ↗ |
| 2024-09-30 | 10-Q | 69.2 | 75.4 | 75.3 | 73.3 | SEC ↗ |
| 2024-06-30 | 10-Q | 69.2 | 73.6 | 76.1 | 73.0 | SEC ↗ |
| 2024-03-31 | 10-Q | 62.0 | 68.5 | 78.1 | 69.5 | SEC ↗ |
| 2023-12-31 | 10-K | 60.0 | 64.6 | 60.4 | 61.6 | SEC ↗ |
| 2023-06-30 | 6-K | 59.7 | 72.8 | 67.6 | 66.7 | SEC ↗ |
| 2023-03-21 | 6-K | 50.0 | 50.0 | 50.0 | 50.0 | SEC ↗ |
| 2022-12-31 | 20-F | 59.0 | 65.7 | 61.5 | 62.1 | SEC ↗ |
| 2020-12-31 | 20-F | 60.2 | 65.7 | 62.5 | 62.8 | SEC ↗ |
| 2019-12-31 | 20-F | 61.5 | 65.5 | 62.8 | 63.2 | SEC ↗ |
| 2018-12-31 | 20-F | 60.9 | 66.5 | 63.9 | 63.8 | SEC ↗ |